Forteo ® (teriparatide [rDNA origin] injection)

20-mcg daily dose in a 2.4-mL prefilled delivery device

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

FORTEO® (teriparatide [rDNA origin] injection): Alternate Injection Sites

Forteo should be administered as a subcutaneous injection into the thigh or abdominal wall.

Detailed Information

Teriparatide should be administered as a subcutaneous injection into the thigh or abdominal wall.1

Subcutaneous Injection

In clinical trials, teriparatide was injected subcutaneously into the patient’s thigh or abdominal wall.1

The upper arm is an acceptable area for subcutaneous injection; however, there are no data available on the injection of teriparatide at this site.

Intravenous or Intramuscular Injection

There is no data available on the safety or efficacy of intravenous or intramuscular injection of teriparatide.

Instructions for Teriparatide Injection

Please review the Forteo® Pen User Manual for instructions on how to properly inject teriparatide.

Enclosed Prescribing Information

FORTEO® (teriparatide [rDNA origin] injection), Lilly

Reference

1. Forteo [package insert]. Indianapolis IN: Eli Lilly and Company; 2019.

Date of Last Review: November 11, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical